Welcome Guest
Home > Clinical Breast Cancer > Volume 6 |  Issue 5

Table of Contents

Volume 6 |  Issue 5

Publication Date: December 2005
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Meeting Highlights
Page Number of this Article in the Print Version
380-384		 Highlights From: ECCO 13–The European Cancer Conference, Paris, France, October 30 to November 3, 2005
G. Kesava Reddy, Chris Schwab, Preeta Tyagi, Eric Nadler, Joyce A. O’Shaughnessy
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
391-401		 The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Gabriel N. Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, Dino Amadori, Renate Haidinger, Clifford A. Hudis, Hussein Khaled, Mei-Ching Liu, Miguel Martin, Moise Namer, Joyce A. O’Shaughnessy, Zhen Zhou Shen, Kathy S. Albain, on Behalf of the ABREAST Investigators
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
402-411		 Concepts and Clinical Trials of Dose-Dense Chemotherapy for Breast Cancer
Jennifer A. Orzano, Sandra M. Swain
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
412-420		 Reducing the Global Breast Cancer Burden: The Importance of Patterns of Care Research
Kathy S. Albain, Jaime de la Garza Salazar, Tadeusz Pienkowski, Matti Aapro, Jonas Bergh, Maira Caleffi, Robert Coleman, Wolfgang Eiermann, Fikri Içli, Mark Pegram, Martine Piccart, Raymond Snyder, Masakazu Toi, Gabriel N. Hortobagyi
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
421-424		 Chemotherapy-Induced Amenorrhea from Adjuvant Breast Cancer Treatment: The Effect of the Addition of Taxanes
Amy L. Davis, Matthew Klitus, David M. Mintzer
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
425-432		 Two Concurrent Phase II Trials of Paclitaxel/ Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252
Edith A. Perez, Vera J. Suman, Kendrith M. Rowland, James N. Ingle, Muhammad Salim, Charles L. Loprinzi, Patrick J. Flynn, James A. Mailliard, Carl G. Kardinal, James E. Krook, Abby R. Thrower, Daniel W. Visscher, Robert B. Jenkins
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
433-438		 Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial
Amadeu Pelegrí, Lourdes Calvo, Antonio Antón, José I. Mayordomo, Jesús Florián, Santiago Vázquez, Angels Arcusa, Marta Martín-Richard, José L. Bayo, Eva Carrasco, Javier Virizuela, for the Spanish Group for Breast Cancer Research (GEICAM)
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
439-445		 Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
Monique G. Lê, Rodrigo Arriagada, Geneviève Contesso, Mohamed Cammoun, Frédérique Pfeiffer, Françoise Tabbane, Jacqueline Bahi, Michèle Dilaj, Marc Spielmann, Jean-Paul Travagli, Thomas Tursz, Nejib Mourali
  • Abstract
  • No Access
  • Add to Cart
Clinical Commentary
Page Number of this Article in the Print Version
455-459		 Statins: Health-Promoting Agents Show Promise for Breast Cancer Prevention
Anjali S. Kumar, Laura J. Esserman
  • Abstract
  • No Access
  • Add to Cart
Current Trial
Page Number of this Article in the Print Version
460-463		 A Pilot Study to Evaluate the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor AZD2171 and Chemotherapy in Locally Advanced and Inflammatory Breast Cancer
Neelima Denduluri, Antoinette R. Tan, Janice Walshe, Arlene Berman, Sherry X. Yang, Catherine K. Chow, Sandra M. Swain
  • Abstract
  • No Access
  • Add to Cart